Pure Global
NCT06361342

Smartphones Aggravating Anxiety Symptoms

Smartphones Aggravating Anxiety Symptoms: Experimental Study From Southeastern
Mayo Clinic·ClinicalTrials.gov·behavioralEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Anxiety
Drug/Device/Intervention
General decrease in smartphone use
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 08, 2024
End date
Mar 01, 2025
Enrollment
100 participants
Primary outcome

Change in anxiety

Summary

The goal of this study is to assess if excessive use of smartphone apps of social media can
 impact a person's mental health. The study is aimed at improving the usage of smartphones
 which might help improve the mental health of patients. The goal is not to discourage the use
 of smartphones but instead to utilize smartphones in a way that they do not impact lives.

ICD-10 classifications
Anxiety disorder, unspecifiedOther anxiety disordersPhobic anxiety disordersPhobic anxiety disorder, unspecifiedGeneralized anxiety disorder
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06361342
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06361342 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Enrolling by invitation. The study focuses on Anxiety. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.